Explore evidence

7 patientsOnly 7 out of 46 patients (15.2%) had the total treatment time within 90 days of symptom onset.

Nigeriacancer du seinpublished 2025BMC cancerPubMeddocument of 11 observations

76.7 %76.7% of respondents were Christians in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.

Nigeriacancer du seinobserved 2018published 2019Journal of global oncologyPubMeddocument of 9 observations

25 %Breast cancer constitutes 25% of all cancer cases diagnosed in Kano State, Nigeria.

Nigeriacancer du seinpublished 2025Breast cancer (Tokyo, Japan)PubMeddocument of 8 observations

44 %Breast cancer has a 5-year survival of 44% in Nigeria.

Nigeriacancer du seinpublished 2026JCO global oncologyPubMeddocument of 3 observations

51.6 %51.6% of respondents had tertiary education in a study of breast cancer patients at University College Hospital, Ibadan, Nigeria.

Nigeriacancer du seinobserved 2018published 2019Journal of global oncologyPubMeddocument of 9 observations

20.61 scoreThe mean breast cancer knowledge score improved from 20.61 ± 13.4 prior to training to 55.93 ± 10.86 following peer training, with p < 0.0001.

Nigeriacancer du seinpublished 2021BMC women's healthPubMeddocument of 4 observations

1.22 odds_ratioA novel breast cancer risk variant in region 5q11.2 has an odds ratio of 1.22 with a 95% confidence interval of 1.09–1.36 and a p-value of 0.00053 in women of African ancestry.

Nigeriacancer du seinpublished 2013Carcinogenesiseurope_pmcdocument of 4 observations

0.028 p_valueBreast cancer risk reduced as socio-economic index increased with p for trend=0.028.

Nigeriacancer du seinpublished 2022The Pan African medical journalPubMeddocument of 5 observations

Breast cancer is the most common cancer and the second leading cause of death among women in Nigeria.

Nigeriacancer du seinpublished 2026JCO global oncologyPubMeddocument of 3 observations

67.6 %67.6% of the respondents were breast cancer patients.

Nigeriacancer du seinpublished 2026BMC women's healthPubMeddocument of 6 observations

862 patientsHealth records of 862 patients with breast cancer were analysed across six tertiary care institutions in Ghana, Kenya, and Nigeria.

Ghana · Kenya · Nigeriacancer du seinobserved 2014 to 2017published 2021BMJ openPubMeddocument of 13 observations

0.965 rA positive significant correlation was observed between total cholesterol and LDL (r = 0.965, p < 0.0001) in the breast cancer patients.

Nigeriacancer du seinpublished 2025Breast cancer (Tokyo, Japan)PubMeddocument of 8 observations

25 %The incidence of breast cancer was highest in patients aged 41–50 years (25%).

Nigeriacancer du seinpublished 2025Breast cancer (Tokyo, Japan)PubMeddocument of 8 observations

12.6 %In the MEND case-control study, 12.6% of Nigerian breast cancer cases were HER2-enriched.

Nigeriacancer du sein · HER2-enrichedpublished 2026Breast cancer research and treatmentPubMeddocument of 10 observations

41.49 %41.49% of the respondents had poor breast self-examination practice.

Nigeriacancer du seinpublished 2023BMC women's healthPubMeddocument of 12 observations

68.5 %Receipt of adjuvant radiotherapy after systemic chemotherapy was associated with improved survival in patients with locally advanced breast cancer in Nigeria between January 2010 and December 2018: 68.5% (95% CI: 46.3 to 86) versus 51% (95% CI: 38.6 to 61.9).

Nigeriacancer du seinobserved 2010–2018published 2021International journal of cancerPubMeddocument of 12 observations

19 %Nineteen percent (n = 42/224) had not heard of breast cancer before diagnosis.

Nigeriacancer du seinpublished 2026Psycho-oncologyPubMeddocument of 11 observations

74.6 %Most participants (74.6%) presented with advanced breast cancers (stage 3 and 4).

Nigeriacancer du seinpublished 2026BMC cancerPubMeddocument of 8 observations

20 %20% of the tumors were progesterone receptor-positive.

Nigeriacancer du seinpublished 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 12 observationsDOI 10.1200/jco.2008.19.6873

1.9 score_unitsThe genetic counseling module showed a mean knowledge score change of 1.9 (95% CI, 1.3 to 2.5) among Nigerian health care providers.

Nigeriacancer du seinpublished 2026JCO global oncologyPubMeddocument of 5 observations

0.419 rA positive significant correlation was observed between LDL and triglycerides (r = 0.419, p = 0.002) in the breast cancer patients.

Nigeriacancer du seinpublished 2025Breast cancer (Tokyo, Japan)PubMeddocument of 8 observations

62 %For postmenopausal women, each standard deviation increase in cumulative lifetime endogenous estrogen exposure (CLEEE) was associated with 62% higher breast cancer odds in multivariable models.

Nigeriacancer du seinpublished 2026Breast cancer research and treatmentPubMeddocument of 10 observations

24 %24% of the tumors were estrogen receptor (ER)-positive.

Nigeriacancer du seinpublished 2009Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument of 12 observationsDOI 10.1200/jco.2008.19.6873

7 %EGFR amplification was found in 7% of breast cancer patients in the study.

Nigeriacancer du seinpublished 2026Cancer geneticsPubMeddocument of 4 observations

10.9 %In the MEND case-control study, 10.9% of Nigerian breast cancer cases were luminal B.

Nigeriacancer du sein · luminal Bpublished 2026Breast cancer research and treatmentPubMeddocument of 10 observations